(Q34710642)

4 August 2017

1 reference

title

Disabling Abl-perspectives on Abl kinase regulation and cancer therapeutics (English)

1 reference

4 August 2017

Charles L Sawyers

1

1 reference

4 August 2017

publication date

1 February 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

13-15

1 reference

An intramolecular SH3-domain interaction regulates c-Abl activity

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Structural basis for selective inhibition of Src family kinases by PP1

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Autoinhibition of c-Abl

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Research on resistance to cancer drug Gleevec

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Crystal structure of the Src family tyrosine kinase Hck

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

Three-dimensional structure of the tyrosine kinase c-Src

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900022-3

7 January 2021

10.1016/S1535-6108(02)00022-3

Identifiers

DOI

1 reference

4 August 2017

1 reference